Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8717041 | The American Journal of Emergency Medicine | 2018 | 7 Pages |
Abstract
Based on the current evidence, the group receiving atropine had reduced hypersalivation and increased rash and tachycardia; no differences were observed in nausea, vomiting, desaturation, agitation and laryngospasm between the two groups. Given that some of the studies were of low quality, additional high-quality randomized controlled trials should be conducted to further verify these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Jiaxiao Shi, Ang Li, Zhijian Wei, Yang Liu, Cong Xing, Hongyu Shi, Han Ding, Dayu Pan, Guangzhi Ning, Shiqing Feng,